SCHEMBL1098686

SCHEMBL1098686

O=S(=O)(c1ccccc1)N(Cc1ccc(F)cc1)c1sc2ccccc2c1Cl

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 5/20 0.48
NR3C1 P04150 1/20 0.45
TAS2R14 Q9NYV8 2/20 0.44
PKM P14618 1/20 0.44
CNR1 P21554 3/20 0.43
CNR2 P34972 3/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
KEAP1 Q14145 1/20 0.42
NFE2L2 Q16236 1/20 0.42
NR1H2 P55055 1/20 0.42
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MAPT P10636 1/20 0.40
RORC P51449 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1098634 0.91 PKM (0.54) TRPM8NR3C1TAS2R14PKMCNR1
SCHEMBL1097984 0.88 MEN1 (0.60) TRPM8NR3C1TAS2R14PKMKMT2A
SCHEMBL1099532 0.88 TRPM8 (0.50) TRPM8PKMKEAP1NFE2L2RORC
SCHEMBL1099475 0.88 TRPM8 (0.53) TRPM8NR3C1PKMCNR1CNR2
SCHEMBL1100034 0.86 TRPM8 (0.48) TRPM8NR3C1TAS2R14CNR1CNR2
SCHEMBL1099655 0.85 TRPM8 (0.67) TRPM8NR3C1KEAP1NFE2L2
SCHEMBL1098784 0.83 TRPM8 (0.68) TRPM8PKMCNR1CNR2KMT2A
SCHEMBL1098457 0.80 NR1I2 (0.44) TRPM8CNR2KMT2AMEN1KEAP1
SCHEMBL11886155 0.80 TRPM8 (0.60) TRPM8NR3C1TAS2R14CNR1CNR2
SCHEMBL1098900 0.79 PKM (0.52) TRPM8NR3C1TAS2R14PKMCNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9434711-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2016-09-06 US disclosed
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-10-23 US disclosed
US-8809327-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2014-08-19 US disclosed
EP-2183239-B1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2012-08-22 EP disclosed
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS BRANUM SHAWN T (US) 2012-07-26 US disclosed
US-8153682-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2012-04-10 US disclosed
CN-101801949-A Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA NV 2010-08-11 CN disclosed
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885NR3C1 2769/4885TAS2R14 182/4885
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885NR3C1 2769/4885TAS2R14 182/4885
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885NR3C1 2769/4885TAS2R14 182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.